Lilly to invest $1.2 billion+ to boost oral medicine manufacturing capacity in US
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
Subscribe To Our Newsletter & Stay Updated